On October 22 Appointed Kameel Farag As Interim CFO - SEC Filing
23/10/2025 23:27
Oct 24 (Reuters) - Akari Therapeutics PLC AKTX.O: AKARI THERAPEUTICS PLC - ON OCTOBER 22 APPOINTED KAMEEL FARAG AS INTERIM CFO - SEC FILING Source text: [ID:n0001493152-25-019112] Further company coverage: AKTX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Akari Therapeutics
See all newsBrief: Akari Therapeutics - Aktx-101 Demonstrates Robust Anti-Tumor Activity In Urothelial Cancer Preclinical Models
UK's Akari Therapeutics Q2 net loss widens on higher R&D for AKTX-101
Akari Therapeutics PLC reports results for the quarter ended June 30 - Earnings Summary
Akari Therapeutics PLC expected to post a loss of $1.40 a share - Earnings Preview
Brief: Akari Therapeutics Enters Strategic Research Collaboration With Whitehawk Therapeutics